EP3370693
Bættar samsetningar af levósímendan til gjafar í bláæð sem innrennsli eða stungulyf og af innrennslisþykkni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
4.11.2016EP published:
8.1.2020EP application number:
16790403.6
EP translation filed:
26.2.2020Grant published:
15.4.2020EPO information:
European Patent Register
Max expiry date:
3.11.2036Expiry date:
3.11.2025Next due date:
30.11.2025
Title:
IMPROVED FORMULATIONS OF LEVOSIMENDAN FOR INTRAVENOUS ADMINISTRATION AS INFUSION OR INJECTION AND OF INFUSION CONCENTRATE
Timeline
Today
4.11.2016EP application
8.1.2020EP Publication
26.2.2020Translation submitted
15.4.2020Registration published
3.11.2025Expires
Owner
Name:
CARINOPHARM GmbHAddress:
Bahnhofstraße 18, 31008 Elze, DE
Inventor
Name:
WEILAND, AndreaAddress:
Hohenbrunn 85662, DE
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
15193521Date:
6.11.2015Country:
EP
Classification
Categories:
A61K 9/08, A61K 9/19, A61K 31/50, A61P 9/04
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 16.11.2020
Expires: 3.11.2021
Payer: Patice ehf.
Number: 6
Paid: 17.11.2021
Expires: 3.11.2022
Payer: Patice ehf.
Number: 7
Paid: 18.11.2022
Expires: 3.11.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 23.11.2023
Expires: 3.11.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 15.11.2024
Expires: 3.11.2025
Payer: Árnason Faktor ehf.